Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study (Q72790325)
Jump to navigation
Jump to search
scientific article published on 01 July 1993
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study |
scientific article published on 01 July 1993 |
Statements
Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study (English)
T A Vandenberg
K I Pritchard
E A Eisenhauer
M E Trudeau
B D Norris
P Lopez
S S Verma
R A Buckman